Strides Pharma Science Sees Revision in Its Score Amid Recent Stock Fluctuations

Strides Pharma Science, a midcap player in the Pharmaceuticals & Drugs industry, has recently experienced notable fluctuations in its stock performance. On January 1, 2025, the stock gained 8.33%, outperforming its sector by 7.27%. This positive momentum has continued, with the stock achieving a consecutive gain over the past two days, resulting in a total return of 7.69% during this period.
Despite these recent gains, the stock's moving averages indicate a mixed performance, as it remains higher than its 5-day moving average but lower than the 20-day, 50-day, 100-day, and 200-day moving averages. On the day of the notable gain, Strides Pharma Science reached an intraday high of Rs 709.8, reflecting a 7.94% increase.

In light of these developments, MarketsMOJO has made an adjustment in its evaluation of Strides Pharma Science, which is now included in its list. Investors and market watchers will be keen to observe how these changes impact the stock's trajectory moving forward.